Search the Newsreel

Elanco (ELAN) Earnings Update: EPS Prints Above Forecast in Latest Trading; Post-Earnings: Shares Move 2.22% Higher at the Close - High Growth Earnings

Primary Health stock trades below peak as market weighs latest portfolio metrics

GE HealthCare names new CFO

GE HealthCare has appointed William Grogan as its new CFO, filling the vacancy left by Jay Saccaro. Grogan, formerly CFO at Xylem, is set to join GE HealthCare on September 14, 2026. Analysts from Stifel and RBC Capital Markets have welcomed the appointment, citing …

Can CVS Health (CVS) Stay Below Fair Value After Strong Results?

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. CVS Health stock has delivered a 58.7% return over the past three years, yet its current valuation checks still lean toward the shares looking inexpensive on several …

SANUWAVE (SNWV) Q2 2026 Earnings Call Transcript

Attention investors: You may be eligible for a $15 million Elanco Animal Health SEC fair fund payment

Investors who purchased Elanco Animal Health (NYSE: ELAN) common stock between May 9, 2019, and May 6, 2020, may be eligible for a payment from a $15 million SEC fair fund. The fund was established after Elanco paid a civil penalty for failing to …

Cardinal Health's Integration of Higher-Margin Services Will Drive Outperformance, RBC Says

Cardinal Health's (CAH) vertical integration of "higher-growth and higher-margin services" will comp PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign …

Cardinal Health (CAH) Taps Anita Zielinski As Chief Accounting Officer

Cardinal Health (NYSE: CAH) has appointed Anita Zielinski as Chief Accounting Officer, bringing extensive financial and operational experience from her previous roles, including interim CFO at Baxter. This strategic hire aligns with Cardinal Health's ongoing transformation efforts, enhancing financial oversight and accountability, especially given …

ETFs Investing in Healthcare Realty Trust Incorporated Class A Stocks

This article lists various Exchange Traded Funds (ETFs) that hold Healthcare Realty Trust Incorporated Class A stocks (HR). It provides a detailed table including each fund's market value, weight, issuer, management style, focus, expense ratio, assets under management (AUM), price, change percentage, relative volume, …

Xunfei Healthcare Technology (SEHK:2506) Stock Sees Revenue Surge While Losses Persist

Cardinal Health a new outperform at RBC on higher margin services

RBC Capital Markets initiated coverage of Cardinal Health (CAH) with an outperform rating, citing the drug wholesaler's potential to benefit from the vertical integration of higher-growth and higher-margin services. The firm set a price target of $276 for CAH, indicating a roughly 17% upside …

ETFs Investing in Ping An Healthcare and Technology Company Limited Stocks

GE HealthCare Hires Bill Grogan as Finance Chief

GE HealthCare has appointed William (Bill) Grogan as its new chief financial officer, effective September 14, 2026. Grogan previously served as executive VP and CFO at Xylem Inc., and held finance leadership roles at IDEX Corp., Walgreens, Crane Co., and Sears Holdings Corp. He …

KeyBanc raises American Healthcare REIT price target on pipeline By Investing.com

KeyBanc has increased its price target for American Healthcare REIT (NYSE:AHR) to $68 from $58, maintaining an Overweight rating, citing the company's strong pipeline and projected growth. This revision follows an increase in 2026 and 2027 normalized funds from operations estimates and accounts for …

Bausch Health (NYSE: BHC) officer may sell stock with vested awards listed

An officer at Bausch Health Companies Inc. (NYSE: BHC), Aimee J. Lenar, has filed a Form 144 indicating an intent to sell common stock under Rule 144. The filing details vested restricted stock awards from various dates in 2025 and 2026, totaling several thousand …

Elanco Animal Health (NYSE:ELAN): Is More Momentum Ahead?

Elanco Animal Health (NYSE:ELAN) has shown improved operating results and raised its full-year revenue outlook, strengthening its recovery narrative. The company's future valuation hinges on sustained commercial execution, successful product launches, margin improvement, and financial discipline through portfolio changes. While recent momentum is positive, …

Lifestance Health Group stock hits 52-week high at 12.85 USD

Lifestance Health Group (LFST) has reached a new 52-week high of $12.85, reflecting a 131.03% increase over the past year. This milestone follows impressive Q2 2026 results, where the company surpassed Wall Street expectations with doubled adjusted earnings, strong revenue growth, and a significant …

Cardinal Health sees 15% revenue growth in Pharma segment, driven by precision medicine and gene therapy.

Cardinal Health's Pharmaceutical and Specialty Solutions segment achieved 15% year-over-year revenue growth in FY2026, reaching $234.8 billion and representing 92% of total company revenues. This growth is attributed to the company's focus on precision medicine and advancements in gene therapy. Despite potential risks from …

Should You Continue to Retain PAHC Stock in Your Portfolio?

Phibro Animal Health Corporation PAHC is well-positioned for growth in the coming quarters, as its Animal Health business continues to gain momentum, bolstered by the addition of Zoetis' medicated feed additive (MFA) portfolio. Its established operations and broad sales, marketing and distribution network give …

Why Ryman Healthcare (NZSE:RYM) Is Back In The Spotlight

Hinge (HNGE) Financial Update: The Available Earnings Metric Delivers a Miss; Price Move

CVS Health (NYSE:CVS) Given New $114.00 Price Target at Argus

Argus has increased its price target for CVS Health (NYSE:CVS) to $114.00 from $104.00, reiterating a "buy" rating, indicating a potential upside of nearly 20%. This positive sentiment is echoed by other analysts, with a consensus "Moderate Buy" rating and an average price target …

Meta Health Sets Joint Chair Transition and Reshapes Board Committees

NHI (NHI) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, Aug. 11, 2026 at 8:30 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer-Eric Mendelsohn Chief Investment Officer-Kevin Pascoe Chief Financial Officer-Todd Siefert Chief Accounting Officer-David Travis Full Conference Call Transcript Operator: Good morning, and welcome to …

Cosmos Health Reports Q2 2026 Results: Record Q2 and H1

Cosmos Health Inc. reported record second quarter and first half 2026 financial results, with Q2 revenue up 29% to $19.0 million and first-half revenue up 30% to $36.9 million. The company also strengthened its balance sheet by reducing total liabilities by 13% and increasing …

Cosmos Health reports record Q2 revenue of $19 million, up 29%

Cosmos Health Inc. (NASDAQ:COSM) announced record second-quarter revenue of $18.99 million, a 28.8% increase year-over-year. First-half revenue also grew by nearly 30% to $36.91 million. Despite a net loss for the quarter, the company saw improved adjusted gross margin and a decrease in total …

Alignment Healthcare stock hits 52-week low at $13.05

Alignment Healthcare (ALHC) stock recently hit a new 52-week low of $13.05, representing a significant year-to-date and six-month decline. Despite this, InvestingPro suggests the stock is oversold and potentially undervalued, with analysts setting higher price targets. The company reported strong Q2 2026 earnings, exceeding …

DarioHealth (NASDAQ:DRIO) Now Covered by Analysts at Alliance Global Partners

Alliance Global Partners has initiated coverage on DarioHealth (NASDAQ:DRIO) with a "buy" rating and a $12 price target, suggesting a potential 67.13% upside. Despite this, analyst opinions remain mixed, resulting in a consensus "Hold" rating and an average target price of $10 for the …

Cardinal Health: Precision Medicine Drives A Sustained Revenue Growth Path (CAH)

Clover (CLOV) Q2 2026 Earnings: EPS Exceeds Its Estimate in the Latest Session; Share Move: Shares Close 1.10% Lower in Latest Trading - Net Income Trends

China Health Technology discloses Shenzhen probe at ginseng unit and completes placing of unsubscribed rights shares

Q1 EPS Forecast for UnitedHealth Group Lifted by Analyst

Zacks Research has increased its Q1 2027 EPS forecast for UnitedHealth Group (NYSE:UNH) to $7.12, maintaining a "Strong Buy" rating. The healthcare conglomerate recently reported Q1 earnings of $6.38 per share, surpassing the consensus estimate, and revenue of $112.03 billion, also exceeding expectations. Analyst …

Option (OPCH) Results Review: EPS Lands Above Forecast in the Latest Session; The Market Price Advances 0.17% on the Day - Return On Assets

Tenet Healthcare (THC) Stock Still Looks Like A Bargain On A 272% Run

DaVita stock slips after Q2 revenue beats forecasts

DaVita Inc. (US23918K1088) reported strong Q2 2026 results, with revenue of $3.55 billion and adjusted EPS of $4.02, exceeding analyst expectations. Despite these positive financial figures and a 5.2% year-over-year revenue increase, the stock experienced a 1.87% decline. Analysts maintain a "Hold" rating with …

Zacks Research Has Positive View of OPKO Health Q3 Earnings